首页 > 最新文献

JEADV clinical practice最新文献

英文 中文
Itch improvement has a major and comparable effect on the Dermatology Life Quality Index in psoriasis and atopic dermatitis patients 瘙痒的改善对银屑病和特应性皮炎患者的皮肤病生活质量指数具有重要且可比的影响
Pub Date : 2024-08-08 DOI: 10.1002/jvc2.509
Wolf-Henning Boehncke, A. Reich, Sonja Ständer, Julio Hernandez, C. Mert, S. Grond, M. J. Rueda, C. Schuster, Gil Yosipovitch
Itch is known to have a particularly high impact on psoriasis (PsO) and atopic dermatitis (AD) patients' quality of life. Although AD therapies have exhibited a high efficacy when it comes to itch control, itch control with PsO therapies is not as well documented.The aim of this post‐hoc analysis is to better understand the impact of itch on the patients' quality of life in PsO as well as AD by providing a pairwise correlation between itch improvement and patients' quality of life and determine the predictive factors in patients achieving Dermatology Life Quality Index score of 0 or 1 [DLQI (0/1)].Three phase III clinical studies, one in PsO and two in AD, were assessed. Pairwise correlations between objective improvement of visible signs of disease, quality of life, and itch intensity were investigated at 16 weeks of treatment. Predictive analyses methods were applied on the data to assess the impact of clinical and itch improvement on the DLQI improvement.This study shows that change in itch from baseline in AD and PsO patients correlate to change in DLQI from baseline. Change in itch from baseline was found to be the most important factor in predicting DLQI (0/1).These results highlight the necessity to study itch in both PsO and AD clinical trials, and it is recommended that itch may be considered a coprimary or at minimum a secondary efficacy end‐point in all such clinical studies.
众所周知,瘙痒对银屑病(PsO)和特应性皮炎(AD)患者的生活质量影响特别大。这项事后分析的目的是通过提供瘙痒改善与患者生活质量之间的成对相关性,更好地了解瘙痒对银屑病和特应性皮炎患者生活质量的影响,并确定皮肤病生活质量指数(DLQI)达到 0 分或 1 分的患者的预测因素。评估了三项 III 期临床研究,其中一项针对 PsO,另两项针对 AD。研究调查了治疗 16 周时疾病可见体征的客观改善、生活质量和瘙痒强度之间的配对相关性。该研究表明,AD 和 PsO 患者瘙痒程度从基线开始的变化与 DLQI 从基线开始的变化相关。这些结果凸显了在 PsO 和 AD 临床试验中研究瘙痒的必要性,建议在所有此类临床研究中将瘙痒视为主要或至少是次要疗效终点。
{"title":"Itch improvement has a major and comparable effect on the Dermatology Life Quality Index in psoriasis and atopic dermatitis patients","authors":"Wolf-Henning Boehncke, A. Reich, Sonja Ständer, Julio Hernandez, C. Mert, S. Grond, M. J. Rueda, C. Schuster, Gil Yosipovitch","doi":"10.1002/jvc2.509","DOIUrl":"https://doi.org/10.1002/jvc2.509","url":null,"abstract":"Itch is known to have a particularly high impact on psoriasis (PsO) and atopic dermatitis (AD) patients' quality of life. Although AD therapies have exhibited a high efficacy when it comes to itch control, itch control with PsO therapies is not as well documented.The aim of this post‐hoc analysis is to better understand the impact of itch on the patients' quality of life in PsO as well as AD by providing a pairwise correlation between itch improvement and patients' quality of life and determine the predictive factors in patients achieving Dermatology Life Quality Index score of 0 or 1 [DLQI (0/1)].Three phase III clinical studies, one in PsO and two in AD, were assessed. Pairwise correlations between objective improvement of visible signs of disease, quality of life, and itch intensity were investigated at 16 weeks of treatment. Predictive analyses methods were applied on the data to assess the impact of clinical and itch improvement on the DLQI improvement.This study shows that change in itch from baseline in AD and PsO patients correlate to change in DLQI from baseline. Change in itch from baseline was found to be the most important factor in predicting DLQI (0/1).These results highlight the necessity to study itch in both PsO and AD clinical trials, and it is recommended that itch may be considered a coprimary or at minimum a secondary efficacy end‐point in all such clinical studies.","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141927095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sjögren syndrome from a dermatological perspective: A retrospective study of 185 SSA‐Ro positive patients 从皮肤科角度看斯约格伦综合征:185 例 SSA-Ro 阳性患者的回顾性研究
Pub Date : 2024-07-19 DOI: 10.1002/jvc2.498
Fiona André, Martha Bujak, Nina Frischhut, Andreas Kronbichler, N. Sepp, G. Ratzinger, Barbara Böckle
Sjögren syndrome (SS) is a systemic autoimmune disease characterised by oral and ocular mucosal dryness.Our study focused on skin manifestations of SS. The differences between primary SS (pSS) and secondary SS (sSS) were investigated. Furthermore, we elucidated factors predicting internal organ involvement.This was a single centre retrospective cohort study. We analysed clinical and laboratory data from 185 Ro‐SSA positive SS patients between January 2000 and December 2016.Skin manifestations were present in 74.9% (n = 137) of SS patients. Dermatitis and Lupus erythematosus (LE)‐specific skin manifestations were present in 34.1% (n = 63) and 21.6% (n = 40) of SS patients respectively. 65.9% (n = 122) of SS patients had internal organ involvement, with 53% (n = 98) presenting neuropsychiatric manifestations. Several risk factors for internal organ involvement were identified: presence of myalgia/arthralgia (odds ratio [OR] = 3.05, confidence interval [CI] 1.29−7.22), fatigue (OR = 2.53, CI 1.11−5.73) and age older than 50 years (OR = 2.23, CI 1.01−4.93).Internal organ involvement is frequent in SS, however there is no significant difference between pSS and sSS concerning its occurrence.
斯约格伦综合征(SS)是一种以口腔和眼部粘膜干燥为特征的全身性自身免疫性疾病。我们的研究侧重于斯约格伦综合征的皮肤表现,调查了原发性斯约格伦综合征(pSS)和继发性斯约格伦综合征(sSS)之间的差异。此外,我们还阐明了预测内脏器官受累的因素。这是一项单中心回顾性队列研究。我们分析了2000年1月至2016年12月期间185名Ro-SSA阳性SSS患者的临床和实验室数据。皮炎和红斑狼疮(LE)特异性皮肤表现分别出现在34.1%(n = 63)和21.6%(n = 40)的SS患者中。65.9%的SS患者(122人)有内脏器官受累,其中53%(98人)有神经精神表现。内脏受累的几个风险因素是:肌痛/关节痛(比值比 [OR] = 3.05,置信区间 [CI] 1.29-7.22)、疲劳(比值比 [OR] = 2.53,置信区间 [CI] 1.11-5.73)和年龄超过 50 岁(比值比 [OR] = 2.23,置信区间 [CI] 1.01-4.93)。
{"title":"Sjögren syndrome from a dermatological perspective: A retrospective study of 185 SSA‐Ro positive patients","authors":"Fiona André, Martha Bujak, Nina Frischhut, Andreas Kronbichler, N. Sepp, G. Ratzinger, Barbara Böckle","doi":"10.1002/jvc2.498","DOIUrl":"https://doi.org/10.1002/jvc2.498","url":null,"abstract":"Sjögren syndrome (SS) is a systemic autoimmune disease characterised by oral and ocular mucosal dryness.Our study focused on skin manifestations of SS. The differences between primary SS (pSS) and secondary SS (sSS) were investigated. Furthermore, we elucidated factors predicting internal organ involvement.This was a single centre retrospective cohort study. We analysed clinical and laboratory data from 185 Ro‐SSA positive SS patients between January 2000 and December 2016.Skin manifestations were present in 74.9% (n = 137) of SS patients. Dermatitis and Lupus erythematosus (LE)‐specific skin manifestations were present in 34.1% (n = 63) and 21.6% (n = 40) of SS patients respectively. 65.9% (n = 122) of SS patients had internal organ involvement, with 53% (n = 98) presenting neuropsychiatric manifestations. Several risk factors for internal organ involvement were identified: presence of myalgia/arthralgia (odds ratio [OR] = 3.05, confidence interval [CI] 1.29−7.22), fatigue (OR = 2.53, CI 1.11−5.73) and age older than 50 years (OR = 2.23, CI 1.01−4.93).Internal organ involvement is frequent in SS, however there is no significant difference between pSS and sSS concerning its occurrence.","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":" August","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib 巴利替尼成功治疗两例粘膜受累的丘疹性荨麻疹病例
Pub Date : 2024-07-19 DOI: 10.1002/jvc2.511
Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs are not yet widely used in autoimmune bullous diseases. We report two recalcitrant cases of pemphigoid with mucous membrane involvement which were successfully treated with the JAK 1/2 inhibitor baricitinib after all other feasible therapeutic options had been exhausted.
大疱性类天疱疮和粘膜大疱性类天疱疮都是自身免疫性大疱性疾病,对个别病例的治疗具有挑战性。Janus 激酶抑制剂已在多种自身免疫性和炎症性疾病中显示出疗效,但这些药物尚未广泛用于自身免疫性大疱性皮肤病。我们报告了两例粘膜受累的顽固性丘疹性荨麻疹病例,在用尽了所有其他可行的治疗方案后,这两例患者成功地接受了JAK 1/2抑制剂巴利替尼的治疗。
{"title":"Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib","authors":"Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy","doi":"10.1002/jvc2.511","DOIUrl":"https://doi.org/10.1002/jvc2.511","url":null,"abstract":"Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs are not yet widely used in autoimmune bullous diseases. We report two recalcitrant cases of pemphigoid with mucous membrane involvement which were successfully treated with the JAK 1/2 inhibitor baricitinib after all other feasible therapeutic options had been exhausted.","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":" February","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141823934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between pemphigus vulgaris and pyoderma gangrenosum 寻常天疱疮与脓皮病之间的联系
Pub Date : 2024-07-08 DOI: 10.1002/jvc2.507
Ana M. Cano, Valentina Burbano, Ricardo A. Rueda

Pyoderma gangrenosum (PG) is a neutrophilic dermatosis associated with certain neoplasms, predominantly of haematological origin, and autoimmune diseases. Pemphigus vulgaris (PV) is a disease in which antibodies target crucial intercellular junction components. A few cases of PG associated with PV have been described. We present a woman with a high phototype presenting this rare association and highlight the diagnostic challenge of diagnosing rare diseases in patients with high phenotypes.

脓皮病(PG)是一种嗜中性皮肤病,与某些肿瘤(主要是血液肿瘤)和自身免疫性疾病有关。寻常天疱疮(PV)是一种抗体针对细胞间关键连接成分的疾病。目前已描述了几例与丘疹性荨麻疹相关的丘疹性荨麻疹病例。我们为大家介绍了一名患有这种罕见并发症的高光型女性患者,并强调了在高光型患者中诊断罕见疾病所面临的挑战。
{"title":"Association between pemphigus vulgaris and pyoderma gangrenosum","authors":"Ana M. Cano,&nbsp;Valentina Burbano,&nbsp;Ricardo A. Rueda","doi":"10.1002/jvc2.507","DOIUrl":"10.1002/jvc2.507","url":null,"abstract":"<p>Pyoderma gangrenosum (PG) is a neutrophilic dermatosis associated with certain neoplasms, predominantly of haematological origin, and autoimmune diseases. Pemphigus vulgaris (PV) is a disease in which antibodies target crucial intercellular junction components. A few cases of PG associated with PV have been described. We present a woman with a high phototype presenting this rare association and highlight the diagnostic challenge of diagnosing rare diseases in patients with high phenotypes.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"902-905"},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.507","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141667259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana 在法属圭亚那使用米替福新治疗皮肤利什曼病
Pub Date : 2024-07-05 DOI: 10.1002/jvc2.400
Charlene Oliveira, Kevin Arrivé, Yannick Andro, Celine Michaud, Kinan Drak Alsibai, Pierre Couppie, Magalie Demar, Romain Blaizot

Background

Nearly half of the cutaneous leishmaniasis (CL) cases in French Guiana occur in remote rainforest areas. The treatment of pentamidine-resistant strains currently requires hospitalisation for intravenous amphotericin, involving significant indirect costs. Miltefosine is currently the only oral drug available but is only used in French Guiana as a third- or fourth-line treatment under a temporary use authorisation.

Objectives

The primary objective of this study was to evaluate the effectiveness of miltefosine in French Guiana. Secondary objectives were to evaluate its safety and acceptability, and patient satisfaction.

Methods

The study was carried out at the Cayenne Hospital and remote health centres in French Guiana. All patients with proven CL and treated with miltefosine between 1 January 2017 and 1 April 2022 were included. Cure was defined as complete re-epithelisation with no new lesions at 90 days. Adherence (all doses taken) and side effects were routinely evaluated at the end of treatment. Patients were retrospectively called back to evaluate the impact of CL on their life quality before treatment and their satisfaction with miltefosine.

Results

Fifteen patients were included. The main species was Leishmania guyanensis (n = 9; 60%), followed by L. braziliensis (n = 4; 26.7%). Eight patients (53.3%) were cured. Eleven patients (73.3%) presented adverse effects (mainly digestive), with seven of these (46.7%) requiring therapeutic adaptations. Eight patients demonstrated complete adherence; of these, six (75%) were cured, including six cases of L. guyanensis, one case of L. braziliensis and one Leishmania spp. Most patients (88.9%) were satisfied with the treatment and said they preferred oral administration to the parenteral route.

Conclusions

Miltefosine is a valuable treatment option for CL in French Guiana. The side effects can diminish patient adherence, but its oral administration is associated with high patient satisfaction. A regular marketing authorisation would facilitate its prescription and allow for the creation of larger cohorts.

法属圭亚那近一半的皮肤利什曼病(CL)病例发生在偏远的热带雨林地区。目前,治疗对喷他脒耐药的菌株需要住院静脉注射两性霉素,间接费用巨大。米替福新是目前唯一可用的口服药物,但在法属圭亚那仅根据临时使用授权作为三线或四线治疗使用。这项研究的主要目的是评估米替福新在法属圭亚那的有效性。该研究在法属圭亚那的卡宴医院和偏远地区的医疗中心进行。所有在2017年1月1日至2022年4月1日期间接受米替福新治疗的确诊CL患者均被纳入研究。治愈的定义是在90天内完全重新上皮且无新病变。在治疗结束时对患者的依从性(服用的所有剂量)和副作用进行常规评估。对患者进行回顾性回访,评估CL对治疗前生活质量的影响以及患者对米替福新的满意度。主要的利什曼原虫是圭亚那利什曼原虫(9;60%),其次是巴西利什曼原虫(4;26.7%)。8 名患者(53.3%)治愈。11名患者(73.3%)出现不良反应(主要是消化系统),其中7名患者(46.7%)需要调整治疗方案。大多数患者(88.9%)对治疗感到满意,并表示他们更喜欢口服给药而不是肠外给药。米替福新在法属圭亚那是治疗CL的重要选择,其副作用会降低患者的依从性,但口服给药的患者满意度很高。米替福新是法属圭亚那治疗慢性淋巴细胞白血病的重要选择,其副作用会降低患者的依从性,但口服给药的患者满意度很高。
{"title":"Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana","authors":"Charlene Oliveira,&nbsp;Kevin Arrivé,&nbsp;Yannick Andro,&nbsp;Celine Michaud,&nbsp;Kinan Drak Alsibai,&nbsp;Pierre Couppie,&nbsp;Magalie Demar,&nbsp;Romain Blaizot","doi":"10.1002/jvc2.400","DOIUrl":"10.1002/jvc2.400","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Nearly half of the cutaneous leishmaniasis (CL) cases in French Guiana occur in remote rainforest areas. The treatment of pentamidine-resistant strains currently requires hospitalisation for intravenous amphotericin, involving significant indirect costs. Miltefosine is currently the only oral drug available but is only used in French Guiana as a third- or fourth-line treatment under a temporary use authorisation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The primary objective of this study was to evaluate the effectiveness of miltefosine in French Guiana. Secondary objectives were to evaluate its safety and acceptability, and patient satisfaction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study was carried out at the Cayenne Hospital and remote health centres in French Guiana. All patients with proven CL and treated with miltefosine between 1 January 2017 and 1 April 2022 were included. Cure was defined as complete re-epithelisation with no new lesions at 90 days. Adherence (all doses taken) and side effects were routinely evaluated at the end of treatment. Patients were retrospectively called back to evaluate the impact of CL on their life quality before treatment and their satisfaction with miltefosine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifteen patients were included. The main species was <i>Leishmania guyanensis</i> (<i>n</i> = 9; 60%), followed by <i>L. braziliensis</i> (<i>n</i> = 4; 26.7%). Eight patients (53.3%) were cured. Eleven patients (73.3%) presented adverse effects (mainly digestive), with seven of these (46.7%) requiring therapeutic adaptations. Eight patients demonstrated complete adherence; of these, six (75%) were cured, including six cases of <i>L. guyanensis</i>, one case of <i>L. braziliensis</i> and one <i>Leishmania</i> spp. Most patients (88.9%) were satisfied with the treatment and said they preferred oral administration to the parenteral route.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Miltefosine is a valuable treatment option for CL in French Guiana. The side effects can diminish patient adherence, but its oral administration is associated with high patient satisfaction. A regular marketing authorisation would facilitate its prescription and allow for the creation of larger cohorts.</p>\u0000 </section>\u0000 </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"850-856"},"PeriodicalIF":0.0,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.400","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141675924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Itchy vesicles on black skin 黑色皮肤上的瘙痒水泡
Pub Date : 2024-07-05 DOI: 10.1002/jvc2.485
Thomas Akel Oberpaur, Tania M. Capusan, Ana R. Gamero Rodríguez, Iván Rodrigo Díaz, Javier Alcántara González, Marta Ruano Del Salado, Cristian Perna, Carla Rodríguez Naranjo, María Elena Sánchez-Largo Uceda

A 60-year-old black woman from Ghana, who had been residing in Spain for over 20 years, was referred to our clinic after presenting progressively itchy lesions following a unilateral knee replacement surgery 4 months ago. Her medical background was notable for obesity, osteoarthritis, hypertension and hypothyroidism. The patient noted the onset of her symptoms once the postoperative pain had subsided. At first, pruritus and dark macules around the scars were believed to be normal but then continued to develop scaly, and itchy plaques predominantly on the extensor surfaces of both her lower limbs. These plaques gradually progressed to cover her back and trunk, sparing the face and mucous membranes. Her condition had not improved with empiric topical corticosteroids before our evaluation.

Upon dermatological examination, she exhibited multiple clear vesicles on erosive, pruritic, lichenified and hyperpigmented plaques (Figure 1). These vesicles were noteworthy for not being fragile or entirely flaccid. Certain blood tests were ordered and an intact vesicle and surrounding skin were excised for microscopic investigation (Figure 2).

PF is a rare subtype of pemphigus, much less frequently encountered than pemphigus vulgaris (PV). It is uncommon globally, with a higher prevalence in endemic areas like Brazil and Africa, more related to geographic and socioeconomic factors rather than ethnicity, age or gender.1 The literature on PF cases in individuals from Africa is limited, though there is a noted higher incidence in South Africa2 and endemic occurrences in the northern African countries and the Kilimanjaro region3 (namely Kenya and Tanzania). Our case exemplifies a sporadic (nonendemic) occurrence of PF, with no related geographical, travel or medication history. Even though triggers are not usually identified, this case seems to have been triggered by the surgery, which has been reported in some other publications.

PF's typical presentation involves painful scaly, erythematous erosions in seborrheic areas, with intact vesicles being a rare find.4, 5 Our case diverges from the norm, as the patient has never noted pain regarding this condition, seborrheic areas are spared at every flare-up and vesicles remain intact for several days. The presence of circulating antibodies targeting Dsg-1, a necessary adhesion molecule in the outer layers of cutaneos epidermis but not indispensable in mucosas, along with preservation of Dsg-3, reflect the physiopathology of this disease and the differences with PV.5 Although we cannot establish why the distribution or the symptoms in our case differs from the classic presentation, we can at least hypothesize that the vesicles are less fragile owing to the more compact corneal layer found in black skin.6 Interestingly, the notorious postinflammatory hyperpig

一位来自加纳的 60 岁黑人妇女在西班牙居住了 20 多年,4 个月前接受了单侧膝关节置换手术,术后出现渐进性瘙痒病变,遂转诊至我院。她的病史包括肥胖、骨关节炎、高血压和甲状腺功能减退。患者指出,她的症状是在术后疼痛缓解后出现的。起初,她认为疤痕周围的瘙痒和深色斑丘疹是正常的,但后来不断出现鳞屑和瘙痒斑块,主要出现在她的双下肢伸肌表面。这些斑块逐渐覆盖了她的背部和躯干,面部和粘膜未受影响。经皮肤科检查,她的糜烂、瘙痒、苔藓化和色素沉着斑块上有多个透明小泡(图 1)。值得注意的是,这些囊泡并不脆弱或完全松弛。患者被要求进行某些血液化验,并切除了一个完整的水泡和周围皮肤进行显微镜检查(图 2)。丘疹性荨麻疹是丘疹性荨麻疹的一种罕见亚型,比寻常型丘疹性荨麻疹(PV)更少见。PF 在全球范围内并不常见,在巴西和非洲等流行地区发病率较高,这与地理和社会经济因素而非种族、年龄或性别有很大关系1 。我们的病例是 PF 的偶发(非流行)病例,没有相关的地理、旅行或用药史。PF 的典型表现是在脂溢区出现疼痛的鳞屑性红斑糜烂,而完整的囊泡则非常罕见。4, 5 我们的病例与常规病例不同,因为患者从未感觉到疼痛,每次发作时脂溢区都会幸免于难,而且囊泡在数天内都保持完整。针对 Dsg-1 的循环抗体的存在(Dsg-1 是角膜表皮外层的一种必要粘附分子,但在粘液中并非不可或缺)以及 Dsg-3 的保留,反映了这种疾病的生理病理以及与角膜营养不良症的不同之处。5 虽然我们无法确定为什么我们病例中的分布或症状与典型表现不同,但我们至少可以假设,由于黑色皮肤的角膜层更紧密,因此囊泡不那么脆弱。有趣的是,深肤色患者的炎症后色素沉着和无红斑有时会误导临床医生,使其无法发现角膜囊泡,这一点在检查不同肤色的患者时必须加以考虑。我们的患者对全身皮质类固醇激素反应良好,但在使用硫唑嘌呤后仍无法停药。她正在考虑接受利妥昔单抗治疗的可能性,根据近年来的证据,利妥昔单抗是一种很好的选择,被认为是一线治疗药物。我们必须训练对不同皮肤表型的诊断准确性:Thomas Akel-Oberpaur 和 Tania M. Capusan。组织学:组织学:克里斯蒂安-佩尔纳(Cristian Perna)和卡拉-罗德里格斯-纳兰霍(Carla Rodríguez Naranjo)。对设计、数据采集和批判性修改知识内容做出重大贡献:Ana R. Gamero Rodríguez、Javier Alcántara González、Marta Ruano Del Salado 和 Iván Rodrigo Díaz。最终批准出版版本:作者声明无利益冲突。本手稿中的患者已书面知情同意参与本研究,并同意将其去标识化、匿名化的汇总数据及其病例细节(包括照片)用于发表。伦理批准:不适用。
{"title":"Itchy vesicles on black skin","authors":"Thomas Akel Oberpaur,&nbsp;Tania M. Capusan,&nbsp;Ana R. Gamero Rodríguez,&nbsp;Iván Rodrigo Díaz,&nbsp;Javier Alcántara González,&nbsp;Marta Ruano Del Salado,&nbsp;Cristian Perna,&nbsp;Carla Rodríguez Naranjo,&nbsp;María Elena Sánchez-Largo Uceda","doi":"10.1002/jvc2.485","DOIUrl":"10.1002/jvc2.485","url":null,"abstract":"<p>A 60-year-old black woman from Ghana, who had been residing in Spain for over 20 years, was referred to our clinic after presenting progressively itchy lesions following a unilateral knee replacement surgery 4 months ago. Her medical background was notable for obesity, osteoarthritis, hypertension and hypothyroidism. The patient noted the onset of her symptoms once the postoperative pain had subsided. At first, pruritus and dark macules around the scars were believed to be normal but then continued to develop scaly, and itchy plaques predominantly on the extensor surfaces of both her lower limbs. These plaques gradually progressed to cover her back and trunk, sparing the face and mucous membranes. Her condition had not improved with empiric topical corticosteroids before our evaluation.</p><p>Upon dermatological examination, she exhibited multiple clear vesicles on erosive, pruritic, lichenified and hyperpigmented plaques (Figure 1). These vesicles were noteworthy for not being fragile or entirely flaccid. Certain blood tests were ordered and an intact vesicle and surrounding skin were excised for microscopic investigation (Figure 2).</p><p>PF is a rare subtype of pemphigus, much less frequently encountered than pemphigus vulgaris (PV). It is uncommon globally, with a higher prevalence in endemic areas like Brazil and Africa, more related to geographic and socioeconomic factors rather than ethnicity, age or gender.<span><sup>1</sup></span> The literature on PF cases in individuals from Africa is limited, though there is a noted higher incidence in South Africa<span><sup>2</sup></span> and endemic occurrences in the northern African countries and the Kilimanjaro region<span><sup>3</sup></span> (namely Kenya and Tanzania). Our case exemplifies a sporadic (nonendemic) occurrence of PF, with no related geographical, travel or medication history. Even though triggers are not usually identified, this case seems to have been triggered by the surgery, which has been reported in some other publications.</p><p>PF's typical presentation involves painful scaly, erythematous erosions in seborrheic areas, with intact vesicles being a rare find.<span><sup>4, 5</sup></span> Our case diverges from the norm, as the patient has never noted pain regarding this condition, seborrheic areas are spared at every flare-up and vesicles remain intact for several days. The presence of circulating antibodies targeting Dsg-1, a necessary adhesion molecule in the outer layers of cutaneos epidermis but not indispensable in mucosas, along with preservation of Dsg-3, reflect the physiopathology of this disease and the differences with PV.<span><sup>5</sup></span> Although we cannot establish why the distribution or the symptoms in our case differs from the classic presentation, we can at least hypothesize that the vesicles are less fragile owing to the more compact corneal layer found in black skin.<span><sup>6</sup></span> Interestingly, the notorious postinflammatory hyperpig","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"934-937"},"PeriodicalIF":0.0,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.485","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141674064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous body image in patients with lichen planus: A cross‐sectional study 扁平苔藓患者的皮肤身体形象:横断面研究
Pub Date : 2024-07-02 DOI: 10.1002/jvc2.505
D. Koumaki, S. Gregoriou, Aikaterini Chatziperrou, Georgios Evangelou, Aikaterini Doxastaki, Konstantinos Krasagakis
{"title":"Cutaneous body image in patients with lichen planus: A cross‐sectional study","authors":"D. Koumaki, S. Gregoriou, Aikaterini Chatziperrou, Georgios Evangelou, Aikaterini Doxastaki, Konstantinos Krasagakis","doi":"10.1002/jvc2.505","DOIUrl":"https://doi.org/10.1002/jvc2.505","url":null,"abstract":"","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"52 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141838113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin diversity and skin of colour 皮肤多样性和有色皮肤
Pub Date : 2024-06-25 DOI: 10.1002/jvc2.496
Nicolas Kluger

Diversity can be defined as ‘all characteristics and experiences that define each of us as individuals’. A common misconception about diversity is that it would only apply to certain persons or groups, while it is the exact opposite. Diversity includes the entire spectrum of primary dimensions of an individual, including ethnicity, gender, age, religion, disability, and sexual orientation. Secondary dimensions commonly include communication style, work style, organizational role/level, economic status, and geographic origin.1 How to define skin diversity in this case? It refers to a wide range of variations in human skin, including differences in colour, textures, tones, and so on, considering genetic factors, environmental exposures, and cultural practices. Understanding skin diversity is crucial for fostering inclusivity and providing effective care tailored to the unique needs of individuals.

For this current special issue on skin diversity of the JEADV Clinical practice, we chose to highlight various aspect around skin of colour (SoC).

The presentation of many skin diseases on SoC may be different from that seen on light skin. An inexperienced practitioner can quickly be in a situation of failure in consultation. The very first step is to sensitize medical students early in their curriculum to SoC.2, 3 Trained residents and graduated practitioners can benefit from university training courses,4 lectures, or workshops in meetings or congresses. The increase of specific iconography featuring SoC in medical atlases is warranted.5 Proper training will help prevent intellectual biases that are not rare in our experience with patients with SoC.6

The proper knowledge of the basic epidemiology of skin diseases among SoC is also crucial. The pattern of skin diseases a dermatologist encounters is way different whether he is an office-based dermatologist in a capital of a Western country, a practitioner working closely with immigrants or refugees that have recently arrived in the country7 or directly in Africa8 or South America.9

A review by Nadège Cordel summarizes the clinical presentation of systemic diseases in Afro-Caribbean patients,10 while several case reports illustrate some conditions that are specific for SoC.11, 12

Lastly, the review by Schuster et al. about the efficacy of of Isobutylamido-Thiazolyl-Resorcinol on hyperpigmentation of the skin13 reminds us that postinflammatory pigmentation and hyperpigmentation in general are frequent and disabling symptoms in persons of colour.

The wide spectrum of topics covered in this special issue of the JEADV clinical practice illustrates how vast the field of skin of colour dermatology is.<

多样性可以定义为 "定义我们每个人的所有特征和经历"。关于多样性的一个常见误解是,它只适用于某些人或群体,而事实恰恰相反。多样性包括个人的所有主要方面,包括种族、性别、年龄、宗教、残疾和性取向。次要层面通常包括沟通方式、工作方式、组织角色/级别、经济状况和地理出身1。它指的是人类皮肤的各种变化,包括颜色、质地、色调等方面的差异,并考虑到遗传因素、环境暴露和文化习俗。了解皮肤的多样性对于促进包容性和根据个人的独特需求提供有效护理至关重要。在本期《JEADV 临床实践》关于皮肤多样性的特刊中,我们选择突出有色人种皮肤(SoC)的各个方面。许多皮肤病在有色人种皮肤上的表现可能不同于在浅色皮肤上的表现。缺乏经验的从业者可能很快就会陷入诊治失败的境地。2, 3 经过培训的住院医师和毕业医师可以从大学培训课程、4 讲座、会议或大会的研讨会中获益。5 适当的培训有助于防止知识偏见,而在我们与 SoC 患者的接触中,这种偏见并不少见。9 Nadège Cordel 的一篇综述总结了非裔加勒比海地区患者全身性疾病的临床表现,10 而一些病例报告则说明了一些非裔加勒比海地区特有的疾病、12 最后,Schuster 等人关于异丁胺基噻唑基间苯二酚对皮肤色素沉着的疗效的综述13 提醒我们,炎症后色素沉着和色素沉着是有色人种经常出现的致残症状。
{"title":"Skin diversity and skin of colour","authors":"Nicolas Kluger","doi":"10.1002/jvc2.496","DOIUrl":"https://doi.org/10.1002/jvc2.496","url":null,"abstract":"<p><i>Diversity</i> can be defined as ‘all characteristics and experiences that define each of us as individuals’. A common misconception about diversity is that it would only apply to certain persons or groups, while it is the exact opposite. Diversity includes the entire spectrum of primary dimensions of an individual, including ethnicity, gender, age, religion, disability, and sexual orientation. Secondary dimensions commonly include communication style, work style, organizational role/level, economic status, and geographic origin.<span><sup>1</sup></span> How to define <i>skin diversity</i> in this case? It refers to a wide range of variations in human skin, including differences in colour, textures, tones, and so on, considering genetic factors, environmental exposures, and cultural practices. Understanding skin diversity is crucial for fostering inclusivity and providing effective care tailored to the unique needs of individuals.</p><p>For this current special issue on skin diversity of the JEADV Clinical practice, we chose to highlight various aspect around skin of colour (SoC).</p><p>The presentation of many skin diseases on SoC may be different from that seen on light skin. An inexperienced practitioner can quickly be in a situation of failure in consultation. The very first step is to sensitize medical students early in their curriculum to SoC.<span><sup>2, 3</sup></span> Trained residents and graduated practitioners can benefit from university training courses,<span><sup>4</sup></span> lectures, or workshops in meetings or congresses. The increase of specific iconography featuring SoC in medical atlases is warranted.<span><sup>5</sup></span> Proper training will help prevent intellectual biases that are not rare in our experience with patients with SoC.<span><sup>6</sup></span></p><p>The proper knowledge of the basic epidemiology of skin diseases among SoC is also crucial. The pattern of skin diseases a dermatologist encounters is way different whether he is an office-based dermatologist in a capital of a Western country, a practitioner working closely with immigrants or refugees that have recently arrived in the country<span><sup>7</sup></span> or directly in Africa<span><sup>8</sup></span> or South America.<span><sup>9</sup></span></p><p>A review by Nadège Cordel summarizes the clinical presentation of systemic diseases in Afro-Caribbean patients,<span><sup>10</sup></span> while several case reports illustrate some conditions that are specific for SoC.<span><sup>11, 12</sup></span></p><p>Lastly, the review by Schuster et al. about the efficacy of of Isobutylamido-Thiazolyl-Resorcinol on hyperpigmentation of the skin<span><sup>13</sup></span> reminds us that postinflammatory pigmentation and hyperpigmentation in general are frequent and disabling symptoms in persons of colour.</p><p>The wide spectrum of topics covered in this special issue of the JEADV clinical practice illustrates how vast the field of skin of colour dermatology is.<","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"793-794"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.496","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photoprotective behaviours amongst persons with albinism in Uyo, Nigeria 尼日利亚乌约白化病患者的防晒行为
Pub Date : 2024-06-14 DOI: 10.1002/jvc2.482
Edesiri E. Ighorodje, Charles N. Nga, Chinyere C. Atansi, Omolara Y. Ukpong, Morolayo O. Fabiyi, Udeme-Abasi U. Nelson

Background

Strict photoprotection is crucial for persons living with albinism (PWAs), especially in Nigeria where the level of solar ultraviolet radiation is particularly high, which further increases the susceptibility of this population to develop photodermatoses and, ultimately, skin cancer.

Objectives

This study aimed to assess the knowledge and attitude towards photoprotection among PWAs in Uyo, Akwa Ibom, Nigeria.

Methods

A descriptive cross-sectional study involving consenting 50 participants with oculocutaneous albinism was recruited through interviewer-administered questionnaires. Data analysis utilised SPSS 26.

Results

The use of sun-protective clothing was the predominant photoprotective measure (62%) with an overall low sun-protection strategy usage of 5% and 10% knowledge rate, despite 80% acknowledging the daily use of various forms of photoprotection. Cost was cited as the commonest deterrent to poor use of sunscreen (47.8%).

Conclusions

Poor awareness and photoprotection usage amongst persons with albinism in Uyo are discouragingly below standard increasing their risk of developing photodermatoses which adversely affects their quality of life. Therefore, dermatologists should improve collaborative efforts at addressing barriers such as cost and enhancing knowledge about effective photoprotection strategies.

本研究旨在评估尼日利亚阿夸伊博姆州乌约市白化病患者的防晒知识和态度。本研究是一项描述性横断面研究,通过访谈员发放问卷的方式招募了 50 名眼部白化病患者,并征得了他们的同意。使用防晒服是最主要的防晒措施(62%),尽管有 80% 的人承认日常使用各种形式的防晒措施,但防晒策略的总体使用率和知识普及率分别为 5%和 10%。在乌约,白化病患者的防晒意识差,防晒措施的使用率低,这令人沮丧地增加了他们患上光敏性皮肤病的风险,对他们的生活质量造成了不利影响。因此,皮肤科医生应加强合作,解决成本等障碍,并提高对有效光防护策略的认识。
{"title":"Photoprotective behaviours amongst persons with albinism in Uyo, Nigeria","authors":"Edesiri E. Ighorodje,&nbsp;Charles N. Nga,&nbsp;Chinyere C. Atansi,&nbsp;Omolara Y. Ukpong,&nbsp;Morolayo O. Fabiyi,&nbsp;Udeme-Abasi U. Nelson","doi":"10.1002/jvc2.482","DOIUrl":"10.1002/jvc2.482","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Strict photoprotection is crucial for persons living with albinism (PWAs), especially in Nigeria where the level of solar ultraviolet radiation is particularly high, which further increases the susceptibility of this population to develop photodermatoses and, ultimately, skin cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aimed to assess the knowledge and attitude towards photoprotection among PWAs in Uyo, Akwa Ibom, Nigeria.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A descriptive cross-sectional study involving consenting 50 participants with oculocutaneous albinism was recruited through interviewer-administered questionnaires. Data analysis utilised SPSS 26.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The use of sun-protective clothing was the predominant photoprotective measure (62%) with an overall low sun-protection strategy usage of 5% and 10% knowledge rate, despite 80% acknowledging the daily use of various forms of photoprotection. Cost was cited as the commonest deterrent to poor use of sunscreen (47.8%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Poor awareness and photoprotection usage amongst persons with albinism in Uyo are discouragingly below standard increasing their risk of developing photodermatoses which adversely affects their quality of life. Therefore, dermatologists should improve collaborative efforts at addressing barriers such as cost and enhancing knowledge about effective photoprotection strategies.</p>\u0000 </section>\u0000 </div>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"876-881"},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.482","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141343668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An insight into racial bias in dermoscopy repositories: A HAM10000 data set analysis 洞察皮肤镜资料库中的种族偏见:HAM10000 数据集分析
Pub Date : 2024-06-14 DOI: 10.1002/jvc2.477
Andres Morales-Forero, Lili Rueda Jaime, Sebastian Ramiro Gil-Quiñones, Marlon Y. Barrera Montañez, Samuel Bassetto, Eric Coatanea

Background

Studies have revealed a lack of representation of skin of colour patients in academic sources of dermatologic diseases, including databases. This visual racism has consequently generated less comfort and confidence among the specialists in the care and attention of this ethnic group, including the opportunity of being correctly diagnosed.

Objectives

To investigate and uncover potential racial biases in the HAM10000 data set through an exploratory analysis of the dark skin tones representation, the identification of inaccuracies in its documentation, the recognition of relevant skin conditions absent for darker skin and the lack of ethnic diversity variables crucial for validating diagnosis across different skin tones.

Methods

An exploratory examination was conducted to investigate the occurrence of dark skin within the HAM10000 database (housed in a Harvard Dataverse repository), consisting of 10,015 dermoscopic images of skin lesions. A visual depiction encompassing the whole skin tones was generated by sampling four crucial data points from each image and applying the Gray World Algorithm for colour normalization. To confirm the accuracy of the graphical representation, dermatologists validated the pixel sampling process by analysing a randomly selected 10% of the images for each type of skin lesion. This visual representation was produced for the entire data set as well as for each skin lesion type. The study was further enhanced by comparing the skin lesion representation within the HAM10000 data set against documented prevalences of relevant conditions affecting dark skin.

Results

Less than 5% of the images came from dark-skinned patients. Nevertheless, in about 4.9% of cases, our pixel sampling method might inadvertently capture shadows or dark spots resulting from the imaging device or the lesion itself rather than the individual's actual skin tone. In addition, there are inaccuracies in the data set's claims of diversity and comprehensive coverage, notably the underrepresentation of conditions prevalent in darker skin and the absence of ethnic diversity variables.

Conclusions

Visual racism is an issue that needs to be addressed in medical sources of information and education. Image databases and artificial intelligence models need to be nourished with

研究表明,在包括数据库在内的皮肤病学术资料中,有色人种患者的代表性不足。通过对深肤色代表的探索性分析、识别记录中的不准确之处、识别深肤色缺失的相关皮肤状况,以及缺乏对不同肤色进行诊断验证至关重要的种族多样性变量,调查并揭示 HAM10000 数据集中潜在的种族偏见。HAM10000 数据库由 10,015 幅皮肤病变的皮肤镜图像组成。通过从每张图像中抽取四个关键数据点,并应用灰色世界算法进行色彩归一化处理,生成了包含整个肤色的可视化描述。为确认图形表示法的准确性,皮肤科医生通过随机抽取 10%的图像对每种皮损类型进行分析,从而验证了像素抽样过程。整个数据集和每种皮损类型都采用了这种可视化表示方法。通过将 HAM10000 数据集中的皮损表示与影响深色皮肤的相关疾病的文献流行率进行比较,这项研究得到了进一步加强。然而,在大约 4.9% 的病例中,我们的像素采样方法可能会无意中捕捉到成像设备或病变本身造成的阴影或黑斑,而不是个人的实际肤色。此外,数据集所宣称的多样性和全面覆盖性也存在不准确之处,尤其是对深色皮肤常见疾病的代表性不足,以及缺乏种族多样性变量。图像数据库和人工智能模型需要丰富的信息,包括所有皮肤类型的信息,以保证获得平等的机会。此外,任何影响有色人种的情况都必须详细记录和报告,以突出并有效解决这些差异。这一点在皮肤镜成像中尤为重要,因为仅仅依靠基于图像的种族偏见分析是有限的。皮肤镜的光线会改变患者的实际肤色,这使得准确评估种族偏见变得更加复杂。
{"title":"An insight into racial bias in dermoscopy repositories: A HAM10000 data set analysis","authors":"Andres Morales-Forero,&nbsp;Lili Rueda Jaime,&nbsp;Sebastian Ramiro Gil-Quiñones,&nbsp;Marlon Y. Barrera Montañez,&nbsp;Samuel Bassetto,&nbsp;Eric Coatanea","doi":"10.1002/jvc2.477","DOIUrl":"10.1002/jvc2.477","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Studies have revealed a lack of representation of skin of colour patients in academic sources of dermatologic diseases, including databases. This visual racism has consequently generated less comfort and confidence among the specialists in the care and attention of this ethnic group, including the opportunity of being correctly diagnosed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To investigate and uncover potential racial biases in the HAM10000 data set through an exploratory analysis of the dark skin tones representation, the identification of inaccuracies in its documentation, the recognition of relevant skin conditions absent for darker skin and the lack of ethnic diversity variables crucial for validating diagnosis across different skin tones.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An exploratory examination was conducted to investigate the occurrence of dark skin within the HAM10000 database (housed in a Harvard Dataverse repository), consisting of 10,015 dermoscopic images of skin lesions. A visual depiction encompassing the whole skin tones was generated by sampling four crucial data points from each image and applying the Gray World Algorithm for colour normalization. To confirm the accuracy of the graphical representation, dermatologists validated the pixel sampling process by analysing a randomly selected 10% of the images for each type of skin lesion. This visual representation was produced for the entire data set as well as for each skin lesion type. The study was further enhanced by comparing the skin lesion representation within the HAM10000 data set against documented prevalences of relevant conditions affecting dark skin.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Less than 5% of the images came from dark-skinned patients. Nevertheless, in about 4.9% of cases, our pixel sampling method might inadvertently capture shadows or dark spots resulting from the imaging device or the lesion itself rather than the individual's actual skin tone. In addition, there are inaccuracies in the data set's claims of diversity and comprehensive coverage, notably the underrepresentation of conditions prevalent in darker skin and the absence of ethnic diversity variables.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Visual racism is an issue that needs to be addressed in medical sources of information and education. Image databases and artificial intelligence models need to be nourished with ","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"3 3","pages":"836-843"},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.477","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141343382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JEADV clinical practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1